Healthcare Swedish Community
Our community narratives are driven by numbers and valuation.
Healthcare Swedish Investing Ideas
19,9% Novo Nordisk ownership on a small swedish biotech - could this be a significant technology?
Nanexa AB is a Swedish pharmaceutical company that specializes in drug delivery systems. Here's a brief overview of its corporate history, ownership, focus, and potential: Corporate History Nanexa was founded in 2007 and is headquartered in Uppsala, Sweden.Read more
EQL Pharma's management aiming for 30% Revenue Growth in 5 Years
2025 Q1 update Strong revenue growth yoy 45% exceding expectations. Strong EPS of 178%, however easy comps should be noted.Read more
Staff Shortages and Demographic Shifts Could Drive Revenue Higher Despite Competition and Regulatory Challenges
Key Takeaways Dedicare holds a robust market position within a steadily expanding market. Continued revenue growth is supported by the persistent need for skilled health professionals.Read more
Leadership Changes And Evolving Market Dynamics Will Shape Future Opportunity
Key Takeaways Expansion in Patient Handling, rental, and new markets supports revenue growth and reduces reliance on mature regions. Demographic shifts and cost efficiency measures strengthen stable, recurring earnings and improve margins.Read more
Transition To SaaS Model Promises Long-term Revenue Stability
Key Takeaways Transition to as-a-service model and cloud solutions is expected to boost revenue stability, growth, and recurring income. Growing demand for Sectra's secure communication and IT solutions is anticipated to drive revenue through increased adoption and customer satisfaction.Read more
Cloud EHR Adoption And AI Tools Will Sustainably Shape Long-Term Earnings Trajectory
Catalysts About Carasent Carasent provides cloud based healthcare software, focusing on EHR platforms and adjacent digital services for clinics in the Nordics and Germany. What are the underlying business or industry changes driving this perspective?Read more
Analysts Keep Xvivo Perfusion Fair Value Steady as Growth and Profit Estimates Slightly Ease
Key Takeaways Regulatory approvals in the U.S. for liver and heart technologies and Canadian market expansions may significantly boost revenue and market share in North America. Strategic improvements in the Abdominal segment are set to increase gross margins and profitability, while strong adoption in Australia indicates promising growth.Read more
Hospital Training Demand Will Drive Long-Term Upside From Advanced Simulation Platforms
Catalysts About Mentice Mentice provides high fidelity virtual simulation solutions for image guided interventional therapies to medical device companies and healthcare providers. What are the underlying business or industry changes driving this perspective?Read more
Infection Prevention Demand Will Drive Licensing Revenue And Margin Expansion Over The Coming Years
Catalysts About Bactiguard Holding Bactiguard Holding develops and licenses infection prevention coating technology and wound management solutions for global MedTech partners. What are the underlying business or industry changes driving this perspective?Read more
